Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 2007

Conditions

AIDS-related Kaposi Sarcoma

Interventions

DRUG

paclitaxel

Given IV

DRUG

pegylated liposomal doxorubicin hydrochloride

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

PROCEDURE

quality-of-life assessment

Ancillary studies

Trial Locations (1)

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00003350 - Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter